First and repeat resection of colorectal liver metastases in elderly patients

被引:78
作者
Zacharias, T [1 ]
Jaeck, D [1 ]
Oussoultzoglou, E [1 ]
Bachellier, P [1 ]
Weber, JC [1 ]
机构
[1] Hop Hautepierre, Ctr Chirurg Viscerale & Transplantat, F-67098 Strasbourg, France
关键词
D O I
10.1097/01.sla.0000143272.52505.d6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to evaluate the short- and long-term outcome after first and repeat resection in patients older than 70 years. Summary Background Data: Liver resection is the best treatment for colorectal liver metastases and is currently increasingly performed in elderly patients. The benefit of resection for these patients needs to be evaluated. Methods: Between 1990 and 2000, 56 first and 16 repeat liver resections were performed in 61 patients older than 70 years. Patients were identified from a prospective database and records were reviewed retrospectively. Results: First and repeat liver resection resulted, respectively, in a 0% and 7% postoperative mortality rate and a 41% and 38% complication rate, respectively. Median survival after first resection of 53 patients with R0 resection was 33 months, and the 5-year survival rate was 22%. Factors associated with poor long-term survival in multivariate analysis were extrahepatic disease, high carcinoembryonic antigen level over 200 ng/mL, and the presence of 3 or more liver metastases. Patients without these risk factors showed a median survival of 42 months and a 5-year survival rate of 36%. Repeat liver resection resulted in a median survival of 17 months and in a 3-year survival rate of 25%. Conclusion: First and repeat liver resection for colorectal liver metastases can be performed safely in patients older than 70 years. A 5-year survival rate similar to those of younger patients can be expected after first liver resection for patients without the presence of risk factors.
引用
收藏
页码:858 / 865
页数:8
相关论文
共 38 条
[1]
[Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
[2]
NATURAL-HISTORY OF PATIENTS WITH UNTREATED LIVER METASTASES FROM COLORECTAL-CANCER [J].
BENGTSSON, G ;
CARLSSON, G ;
HAFSTROM, L ;
JONSSON, P .
AMERICAN JOURNAL OF SURGERY, 1981, 141 (05) :586-589
[3]
Brand MI, 2000, AM SURGEON, V66, P412
[4]
Brunken C, 1998, CHIRURG, V69, P1334, DOI 10.1007/s001040050580
[5]
COOPER GS, 1995, CANCER, V75, P775, DOI 10.1002/1097-0142(19950201)75:3<775::AID-CNCR2820750305>3.0.CO
[6]
2-D
[7]
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].
Cunningham, D ;
Pyrhönen, S ;
James, RD ;
Punt, CJA ;
Hickish, TF ;
Heikkila, R ;
Johannesen, TB ;
Starkhammar, H ;
Topham, CA ;
Awad, L ;
Jacques, C ;
Herait, P .
LANCET, 1998, 352 (9138) :1413-1418
[8]
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[9]
Preoperative portal vein embolization for extension of hepatectomy indications [J].
deBaere, T ;
Roche, A ;
Elias, D ;
Lasser, P ;
Lagrange, C ;
Bousson, V .
HEPATOLOGY, 1996, 24 (06) :1386-1391
[10]
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases [J].
Elias, D ;
Ouellet, JF ;
Bellon, N ;
Pignon, JP ;
Pocard, M ;
Lasser, P .
BRITISH JOURNAL OF SURGERY, 2003, 90 (05) :567-574